Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia

go back to reference Young NS (2018) Aplastic Anemia. N Engl J Med 379(17):1643–1656. https://doi.org/10.1056/NEJMra1413485CrossRefPubMedPubMedCentral Young NS (2018) Aplastic Anemia. N Engl J Med 379(17):1643–1656. https://​doi.​org/​10.​1056/​NEJMra1413485CrossRefPubMedPubMedCentral

go back to reference Akram Z, Ahmed P, Kajigaya S, Satti TM, Satti HS, Chaudhary QUN, Gutierrez-Rodrigues F, Ibanez PF, Feng X, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Sultan A (2019) Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan. Ann Hematol 98(2):301–312. https://doi.org/10.1007/s00277-018-3542-zCrossRefPubMed Akram Z, Ahmed P, Kajigaya S, Satti TM, Satti HS, Chaudhary QUN, Gutierrez-Rodrigues F, Ibanez PF, Feng X, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Sultan A (2019) Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan. Ann Hematol 98(2):301–312. https://​doi.​org/​10.​1007/​s00277-018-3542-zCrossRefPubMed

go back to reference Giudice V, Cardamone C, Triggiani M, Selleri C (2021) Bone marrow failure syndromes, overlapping diseases with a common cytokine signature. Int J Mol Sci 22(2):705. https://doi.org/10.3390/ijms22020705CrossRefPubMedPubMedCentral Giudice V, Cardamone C, Triggiani M, Selleri C (2021) Bone marrow failure syndromes, overlapping diseases with a common cytokine signature. Int J Mol Sci 22(2):705. https://​doi.​org/​10.​3390/​ijms22020705CrossRefPubMedPubMedCentral

go back to reference Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German aplastic Anemia Study Group. N Engl J Med 324(19):1297–1304. https://doi.org/10.1056/nejm199105093241901CrossRefPubMed Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German aplastic Anemia Study Group. N Engl J Med 324(19):1297–1304. https://​doi.​org/​10.​1056/​nejm199105093241​901CrossRefPubMed

go back to reference Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85(11):3058–3065CrossRefPubMed Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85(11):3058–3065CrossRefPubMed

go back to reference Dao AT, Yamazaki H, Takamatsu H, Sugimori C, Katagiri T, Maruyama H, Zaimoku Y, Maruyama K, Ly TQ, Espinoza L, Nakao S (2016) Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia. Ann Hematol 95(5):771–781. https://doi.org/10.1007/s00277-016-2629-7CrossRefPubMed Dao AT, Yamazaki H, Takamatsu H, Sugimori C, Katagiri T, Maruyama H, Zaimoku Y, Maruyama K, Ly TQ, Espinoza L, Nakao S (2016) Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia. Ann Hematol 95(5):771–781. https://​doi.​org/​10.​1007/​s00277-016-2629-7CrossRefPubMed

go back to reference Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130–1135. https://doi.org/10.1001/jama.289.9.1130CrossRefPubMed Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130–1135. https://​doi.​org/​10.​1001/​jama.​289.​9.​1130CrossRefPubMed

go back to reference Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A (2000) Late clonal diseases of treated aplastic anemia. Semin Hematol 37(1):91–101CrossRefPubMed Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A (2000) Late clonal diseases of treated aplastic anemia. Semin Hematol 37(1):91–101CrossRefPubMed

go back to reference Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365(5):430–438. https://doi.org/10.1056/NEJMoa1103975CrossRefPubMedPubMedCentral Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365(5):430–438. https://​doi.​org/​10.​1056/​NEJMoa1103975CrossRefPubMedPubMedCentral

go back to reference Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, Sugita K, Yabe H, Ohara A, Tsukimoto I (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96(6):2049–2054CrossRefPubMed Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, Sugita K, Yabe H, Ohara A, Tsukimoto I (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96(6):2049–2054CrossRefPubMed

go back to reference Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Wu CO, Young NS (2012) Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood 119(2):345–354. https://doi.org/10.1182/blood-2011-05-352328CrossRefPubMedPubMedCentral Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Wu CO, Young NS (2012) Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood 119(2):345–354. https://​doi.​org/​10.​1182/​blood-2011-05-352328CrossRefPubMedPubMedCentral

go back to reference Scheinberg P, Nunez O, Wu C, Young NS (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 133(6):606–611. https://doi.org/10.1111/j.1365-2141.2006.06085.xCrossRefPubMed Scheinberg P, Nunez O, Wu C, Young NS (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 133(6):606–611. https://​doi.​org/​10.​1111/​j.​1365-2141.​2006.​06085.​xCrossRefPubMed

go back to reference Scheinberg P, Wu CO, Nunez O, Scheinberg P, Boss C, Sloand EM, Young NS (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 94(3):348–354. https://doi.org/10.3324/haematol.13829CrossRefPubMedPubMedCentral Scheinberg P, Wu CO, Nunez O, Scheinberg P, Boss C, Sloand EM, Young NS (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 94(3):348–354. https://​doi.​org/​10.​3324/​haematol.​13829CrossRefPubMedPubMedCentral

go back to reference Kurita N, Nishikii H, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Kato T, Yokoyama Y, Obara N, Maruo K, Ohigashi T, Yamaguchi H, Iwamoto T, Minohara H, Matsuoka R, Hashimoto K, Sakata-Yanagimoto M, Chiba S (2023) Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial. Ann Hematol. https://doi.org/10.1007/s00277-023-05410-3CrossRefPubMed Kurita N, Nishikii H, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Kato T, Yokoyama Y, Obara N, Maruo K, Ohigashi T, Yamaguchi H, Iwamoto T, Minohara H, Matsuoka R, Hashimoto K, Sakata-Yanagimoto M, Chiba S (2023) Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial. Ann Hematol. https://​doi.​org/​10.​1007/​s00277-023-05410-3CrossRefPubMed

go back to reference Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133–1163. https://doi.org/10.1002/sim.3034CrossRefPubMed Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133–1163. https://​doi.​org/​10.​1002/​sim.​3034CrossRefPubMed

go back to reference Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16(4):309–330. https://doi.org/10.1177/0962280206077743CrossRefPubMed Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16(4):309–330. https://​doi.​org/​10.​1177/​0962280206077743​CrossRefPubMed

go back to reference Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1(8479):507–508. https://doi.org/10.1016/s0140-6736(86)92972-7CrossRefPubMed Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1(8479):507–508. https://​doi.​org/​10.​1016/​s0140-6736(86)92972-7CrossRefPubMed

go back to reference Sekula P, Del Greco MF, Pattaro C, Köttgen A (2016) Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol 27(11):3253–3265. https://doi.org/10.1681/asn.2016010098CrossRefPubMedPubMedCentral Sekula P, Del Greco MF, Pattaro C, Köttgen A (2016) Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol 27(11):3253–3265. https://​doi.​org/​10.​1681/​asn.​2016010098CrossRefPubMedPubMedCentral

go back to reference Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, Tyl B, Chopade S, Faraway R, Zwierzyna M, Hingorani AD (2020) Genetic drug target validation using mendelian randomisation. Nat Commun 11(1):3255. https://doi.org/10.1038/s41467-020-16969-0CrossRefPubMedPubMedCentral Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, Tyl B, Chopade S, Faraway R, Zwierzyna M, Hingorani AD (2020) Genetic drug target validation using mendelian randomisation. Nat Commun 11(1):3255. https://​doi.​org/​10.​1038/​s41467-020-16969-0CrossRefPubMedPubMedCentral

go back to reference Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, Oliver-Williams C, Kamat MA, Prins BP, Wilcox SK, Zimmerman ES, Chi A, Bansal N, Spain SL, Wood AM, Morrell NW, Bradley JR, Janjic N, Roberts DJ, Ouwehand WH, Todd JA, Soranzo N, Suhre K, Paul DS, Fox CS, Plenge RM, Danesh J, Runz H, Butterworth AS (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73–79. https://doi.org/10.1038/s41586-018-0175-2CrossRefPubMedPubMedCentral Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, Oliver-Williams C, Kamat MA, Prins BP, Wilcox SK, Zimmerman ES, Chi A, Bansal N, Spain SL, Wood AM, Morrell NW, Bradley JR, Janjic N, Roberts DJ, Ouwehand WH, Todd JA, Soranzo N, Suhre K, Paul DS, Fox CS, Plenge RM, Danesh J, Runz H, Butterworth AS (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73–79. https://​doi.​org/​10.​1038/​s41586-018-0175-2CrossRefPubMedPubMedCentral

go back to reference Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, Galver L, Kelley R, Karlsson A, Santos R, Overington JP, Hingorani AD, Casas JP (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383). https://doi.org/10.1126/scitranslmed.aag1166 Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, Galver L, Kelley R, Karlsson A, Santos R, Overington JP, Hingorani AD, Casas JP (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383). https://​doi.​org/​10.​1126/​scitranslmed.​aag1166

go back to reference Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, Lambourne JJ, Sivapalaratnam S, Downes K, Kundu K, Bomba L, Berentsen K, Bradley JR, Daugherty LC, Delaneau O, Freson K, Garner SF, Grassi L, Guerrero J, Haimel M, Janssen-Megens EM, Kaan A, Kamat M, Kim B, Mandoli A, Marchini J, Martens JHA, Meacham S, Megy K, O’Connell J, Petersen R, Sharifi N, Sheard SM, Staley JR, Tuna S, van der Ent M, Walter K, Wang SY, Wheeler E, Wilder SP, Iotchkova V, Moore C, Sambrook J, Stunnenberg HG, Di Angelantonio E, Kaptoge S, Kuijpers TW, Carrillo-de-Santa-Pau E, Juan D, Rico D, Valencia A, Chen L, Ge B, Vasquez L, Kwan T, Garrido-Martín D, Watt S, Yang Y, Guigo R, Beck S, Paul DS, Pastinen T, Bujold D, Bourque G, Frontini M, Danesh J, Roberts DJ, Ouwehand WH, Butterworth AS, Soranzo N (2016) The allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell 167(5):1415–1429e1419. https://doi.org/10.1016/j.cell.2016.10.042CrossRefPubMedPubMedCentral Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, Lambourne JJ, Sivapalaratnam S, Downes K, Kundu K, Bomba L, Berentsen K, Bradley JR, Daugherty LC, Delaneau O, Freson K, Garner SF, Grassi L, Guerrero J, Haimel M, Janssen-Megens EM, Kaan A, Kamat M, Kim B, Mandoli A, Marchini J, Martens JHA, Meacham S, Megy K, O’Connell J, Petersen R, Sharifi N, Sheard SM, Staley JR, Tuna S, van der Ent M, Walter K, Wang SY, Wheeler E, Wilder SP, Iotchkova V, Moore C, Sambrook J, Stunnenberg HG, Di Angelantonio E, Kaptoge S, Kuijpers TW, Carrillo-de-Santa-Pau E, Juan D, Rico D, Valencia A, Chen L, Ge B, Vasquez L, Kwan T, Garrido-Martín D, Watt S, Yang Y, Guigo R, Beck S, Paul DS, Pastinen T, Bujold D, Bourque G, Frontini M, Danesh J, Roberts DJ, Ouwehand WH, Butterworth AS, Soranzo N (2016) The allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell 167(5):1415–1429e1419. https://​doi.​org/​10.​1016/​j.​cell.​2016.​10.​042CrossRefPubMedPubMedCentral

go back to reference Orrù V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A, Virdis F, Piras MG, Lobina M, Marongiu M, Pitzalis M, Deidda F, Loizedda A, Onano S, Zoledziewska M, Sawcer S, Devoto M, Gorospe M, Abecasis GR, Floris M, Pala M, Schlessinger D, Fiorillo E, Cucca F (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036–1045. https://doi.org/10.1038/s41588-020-0684-4CrossRefPubMedPubMedCentral Orrù V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A, Virdis F, Piras MG, Lobina M, Marongiu M, Pitzalis M, Deidda F, Loizedda A, Onano S, Zoledziewska M, Sawcer S, Devoto M, Gorospe M, Abecasis GR, Floris M, Pala M, Schlessinger D, Fiorillo E, Cucca F (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036–1045. https://​doi.​org/​10.​1038/​s41588-020-0684-4CrossRefPubMedPubMedCentral

go back to reference Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AAM, Jonkers D, Oosting M, Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI (2019) Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 51(4):600–605. https://doi.org/10.1038/s41588-019-0350-xCrossRefPubMedPubMedCentral Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AAM, Jonkers D, Oosting M, Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI (2019) Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 51(4):600–605. https://​doi.​org/​10.​1038/​s41588-019-0350-xCrossRefPubMedPubMedCentral

go back to reference Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, Smoller JW (2019) Assessment of Bidirectional relationships between physical activity and depression among adults: a 2-Sample mendelian randomization study. JAMA Psychiatry 76(4):399–408. https://doi.org/10.1001/jamapsychiatry.2018.4175CrossRefPubMedPubMedCentral Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, Smoller JW (2019) Assessment of Bidirectional relationships between physical activity and depression among adults: a 2-Sample mendelian randomization study. JAMA Psychiatry 76(4):399–408. https://​doi.​org/​10.​1001/​jamapsychiatry.​2018.​4175CrossRefPubMedPubMedCentral

go back to reference Yang J, He X, Qian L, Zhao B, Fan Y, Gao F, Yan B, Zhu F, Ma X (2022) Association between plasma proteome and childhood neurodevelopmental disorders: a two-sample mendelian randomization analysis. EBioMedicine 78:103948. https://doi.org/10.1016/j.ebiom.2022.103948CrossRefPubMedPubMedCentral Yang J, He X, Qian L, Zhao B, Fan Y, Gao F, Yan B, Zhu F, Ma X (2022) Association between plasma proteome and childhood neurodevelopmental disorders: a two-sample mendelian randomization analysis. EBioMedicine 78:103948. https://​doi.​org/​10.​1016/​j.​ebiom.​2022.​103948CrossRefPubMedPubMedCentral

go back to reference Brion MJ, Shakhbazov K, Visscher PM (2013) Calculating statistical power in mendelian randomization studies. Int J Epidemiol 42(5):1497–1501. https://doi.org/10.1093/ije/dyt179CrossRefPubMed Brion MJ, Shakhbazov K, Visscher PM (2013) Calculating statistical power in mendelian randomization studies. Int J Epidemiol 42(5):1497–1501. https://​doi.​org/​10.​1093/​ije/​dyt179CrossRefPubMed

go back to reference Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://doi.org/10.1002/gepi.21758CrossRefPubMedPubMedCentral Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://​doi.​org/​10.​1002/​gepi.​21758CrossRefPubMedPubMedCentral

go back to reference Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol 40(3):755–764. https://doi.org/10.1093/ije/dyr036CrossRefPubMed Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol 40(3):755–764. https://​doi.​org/​10.​1093/​ije/​dyr036CrossRefPubMed

go back to reference Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, Berndt SI, Timothy Bishop D, Brenner H, Buchanan DD, Bueno-de-Mesquita B, Campbell PT, Castellví-Bel S, Chan AT, Chang-Claude J, Ellingjord-Dale M, Figueiredo JC, Gallinger SJ, Giles GG, Giovannucci E, Gruber SB, Gsur A, Hampe J, Hampel H, Harlid S, Harrison TA, Hoffmeister M, Hopper JL, Hsu L, María Huerta J, Huyghe JR, Jenkins MA, Keku TO, Kühn T, La Vecchia C, Le Marchand L, Li CI, Li L, Lindblom A, Lindor NM, Lynch B, Markowitz SD, Masala G, May AM, Milne R, Monninkhof E, Moreno L, Moreno V, Newcomb PA, Offit K, Perduca V, Pharoah PDP, Platz EA, Potter JD, Rennert G, Riboli E, Sánchez M-J, Schmit SL, Schoen RE, Severi G, Sieri S, Slattery ML, Song M, Tangen CM, Thibodeau SN, Travis RC, Trichopoulou A, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Vodicka P, White E, Wolk A, Woods MO, Wu AH, Peters U, Gunter MJ, Murphy N (2020) Physical activity and risks of breast and colorectal cancer: a mendelian randomisation analysis. Nat Commun 11(1):597–597. https://doi.org/10.1038/s41467-020-14389-8CrossRefPubMedPubMedCentral Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, Berndt SI, Timothy Bishop D, Brenner H, Buchanan DD, Bueno-de-Mesquita B, Campbell PT, Castellví-Bel S, Chan AT, Chang-Claude J, Ellingjord-Dale M, Figueiredo JC, Gallinger SJ, Giles GG, Giovannucci E, Gruber SB, Gsur A, Hampe J, Hampel H, Harlid S, Harrison TA, Hoffmeister M, Hopper JL, Hsu L, María Huerta J, Huyghe JR, Jenkins MA, Keku TO, Kühn T, La Vecchia C, Le Marchand L, Li CI, Li L, Lindblom A, Lindor NM, Lynch B, Markowitz SD, Masala G, May AM, Milne R, Monninkhof E, Moreno L, Moreno V, Newcomb PA, Offit K, Perduca V, Pharoah PDP, Platz EA, Potter JD, Rennert G, Riboli E, Sánchez M-J, Schmit SL, Schoen RE, Severi G, Sieri S, Slattery ML, Song M, Tangen CM, Thibodeau SN, Travis RC, Trichopoulou A, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Vodicka P, White E, Wolk A, Woods MO, Wu AH, Peters U, Gunter MJ, Murphy N (2020) Physical activity and risks of breast and colorectal cancer: a mendelian randomisation analysis. Nat Commun 11(1):597–597. https://​doi.​org/​10.​1038/​s41467-020-14389-8CrossRefPubMedPubMedCentral

go back to reference Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, Jalkanen S, Maksimow M, Salomaa V, Salmi M, Kettunen J, Raitakari OT (2017) Genome-wide Association Study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet 100(1):40–50. https://doi.org/10.1016/j.ajhg.2016.11.007CrossRefPubMed Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, Jalkanen S, Maksimow M, Salomaa V, Salmi M, Kettunen J, Raitakari OT (2017) Genome-wide Association Study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet 100(1):40–50. https://​doi.​org/​10.​1016/​j.​ajhg.​2016.​11.​007CrossRefPubMed

go back to reference Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://doi.org/10.1002/gepi.21965CrossRefPubMedPubMedCentral Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://​doi.​org/​10.​1002/​gepi.​21965CrossRefPubMedPubMedCentral

go back to reference Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://doi.org/10.1093/ije/dyv080CrossRefPubMedPubMedCentral Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://​doi.​org/​10.​1093/​ije/​dyv080CrossRefPubMedPubMedCentral

go back to reference Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat Med 36(11):1783–1802. https://doi.org/10.1002/sim.7221CrossRefPubMedPubMedCentral Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat Med 36(11):1783–1802. https://​doi.​org/​10.​1002/​sim.​7221CrossRefPubMedPubMedCentral

go back to reference Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698. https://doi.org/10.1038/s41588-018-0099-7CrossRefPubMedPubMedCentral Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698. https://​doi.​org/​10.​1038/​s41588-018-0099-7CrossRefPubMedPubMedCentral

go back to reference Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7. https://doi.org/10.7554/eLife.34408 Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7. https://​doi.​org/​10.​7554/​eLife.​34408

go back to reference Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 82(1):188–192. https://doi.org/10.1073/pnas.82.1.188CrossRefPubMedPubMedCentral Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 82(1):188–192. https://​doi.​org/​10.​1073/​pnas.​82.​1.​188CrossRefPubMedPubMedCentral

go back to reference Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS (1985) Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312(5):257–265. https://doi.org/10.1056/nejm198501313120501CrossRefPubMed Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS (1985) Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312(5):257–265. https://​doi.​org/​10.​1056/​nejm198501313120​501CrossRefPubMed

go back to reference Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP (1995) Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165(3):538–546. https://doi.org/10.1002/jcp.1041650312CrossRefPubMed Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP (1995) Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165(3):538–546. https://​doi.​org/​10.​1002/​jcp.​1041650312CrossRefPubMed

go back to reference Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100(4):1185–1191. https://doi.org/10.1182/blood-2002-01-0035CrossRefPubMed Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100(4):1185–1191. https://​doi.​org/​10.​1182/​blood-2002-01-0035CrossRefPubMed

go back to reference Maciejewski J, Selleri C, Anderson S, Young NS (1995) Fas antigen expression on CD34 + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85(11):3183–3190CrossRefPubMed Maciejewski J, Selleri C, Anderson S, Young NS (1995) Fas antigen expression on CD34 + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85(11):3183–3190CrossRefPubMed

go back to reference Luzzatto L, Risitano AM (2018) Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol 182(6):758–776. https://doi.org/10.1111/bjh.15443CrossRefPubMed Luzzatto L, Risitano AM (2018) Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol 182(6):758–776. https://​doi.​org/​10.​1111/​bjh.​15443CrossRefPubMed